The Hidden Revenue in Your Quality Scores

Most hospital CFOs and revenue cycle leaders think of HEDIS scores and Medicare Star Ratings as a quality department problem. Something to hand off to a clinical quality team, monitor quarterly, and address through outreach campaigns and care gap closure initiatives.

That framing is costing health systems real money. Quality scores are a revenue problem, and the financial stakes attached to them have grown large enough that they belong in every CFO's weekly dashboard alongside denial rates and AR days.

The Financial Stakes Are Not Subtle

Medicare Advantage quality bonus payments totaled at least $12.7 billion in 2025, according to KFF analysis of CMS data. That figure has more than quadrupled since 2015, when it stood at $3 billion. The money flows to plans rated four stars and above. Plans below that threshold receive no quality bonus payment at all.

The stakes at the individual plan level are equally stark. When Aetna's star ratings declined, the company projected losses of up to $1 billion in 2024 bonus payments. Elevance projected a $500 million loss from the same cause. Both companies sued CMS over the methodology. SCAN Health Plan, which dropped from 4.5 stars to 3.5 stars, stood to lose $250 million. These are not rounding errors. They are existential financial events driven by quality measure performance.

The bar has gotten materially harder to clear. In 2022, 68% of Medicare Advantage plans received four or more stars. By 2025 that figure had dropped to 40%. Only seven plans out of hundreds achieved five stars in 2025, compared to 38 in 2024. CMS has been raising cut points consistently, meaning plans need to perform better every year just to hold their rating.

For health systems with employed physicians, affiliated medical groups, or value-based contracts tied to quality performance, this trajectory runs directly into your revenue projections.

Where the Scores Are Actually Being Lost

Here is where the clinical quality framing breaks down. The majority of HEDIS measure failures are not caused by poor care. They are caused by care that was delivered but never documented in a way that HEDIS can count.

HEDIS offers no partial credit. Missing data is treated identically to care that never happened. A mammogram performed at an out-of-network facility, a diabetic A1c drawn at an independent lab, a colorectal screening completed during a previous health system relationship -- if that documentation does not exist in a retrievable, compliant format within the measurement year, the care gap stays open. The score suffers. The bonus payment is at risk.

The timing dimension compounds the problem. HEDIS measurement year 2025 runs January 1 through December 31. Reporting and validation extend into the following year, with supplemental data submission deadlines in January 2026. Services rendered early in the year may not surface in a review until April or May of the following year. At that point, coding corrections and documentation amendments are no longer permitted. The lost quality credit is permanent.

The Out-of-Network Problem No One Is Pricing In

There is a specific category of HEDIS loss that most quality teams are not adequately accounting for: care that was delivered outside your network and simply never made it back into your documentation.

Consider what this looks like in practice.

More than 90% of U.S. health plans report HEDIS results. With 235 million Americans enrolled in those plans, the volume of out-of-network encounters that never make it back to the primary treating organization is substantial. Each one is a potential care gap that was already closed but still shows as open in your data.

Quality Scores and Your Revenue Cycle Are the Same Problem

The connection between incomplete records and revenue is not theoretical. It runs through three specific mechanisms that every health system finance leader should understand.

The first is direct bonus payment eligibility. Plans and health systems in value-based arrangements that hit quality thresholds receive bonus payments. Those that fall short do not. The gap between 3.5 stars and 4 stars is not a clinical distinction. It is a financial one measured in millions of dollars per year.

The second is value-based contract positioning. Payers building accountable care arrangements and shared savings programs are choosing provider partners based on demonstrated quality performance. Health systems with strong HEDIS and Stars performance have leverage in those negotiations. Those with weak performance do not, regardless of what their actual care delivery looks like.

The third is the compounding effect of undocumented care. Every care gap that shows as open in your data -- even if the underlying care was actually delivered elsewhere -- drags your composite quality score. Lower scores mean lower benchmarks. Lower benchmarks mean lower reimbursement rates across your entire value-based portfolio.

What the Highest-Performing Systems Are Doing Differently

The health systems closing this gap are not investing in better clinical protocols. Their clinical care is already strong. What they are investing in is complete documentation -- specifically, the retrieval and integration of out-of-network care history that their EHR was never designed to capture on its own.

When a care gap that was already closed gets properly documented, it moves from a liability to a credit. The clinical work was already done. The only thing missing was the record. Recovering that record does not require seeing the patient again, ordering another test, or changing any clinical workflow. It requires solving the documentation problem.

The financial return on closing documented care gaps is direct and measurable. Humana's 2024 Value-Based Care Report found that its Medicare Advantage value-based arrangements generated an estimated $11 billion in medical cost savings in 2023. The organizations contributing to that performance were capturing quality credit systematically, not episodically.

The systems that treat quality score performance as a revenue strategy, rather than a compliance exercise, are the ones positioned to compete in a value-based contracting environment where the bar continues to rise and the financial consequences of underperformance continue to grow.